Neuronal signaling modulates protein homeostasis in Caenorhabditis elegans post-synaptic muscle cells

Genes and Development

Volumn 21, Issue 22, 2007, Pages 3006-3016

  Garcia, Susana M ^a,b   Casanueva, M Olivia ^a   Silva, M Catarina ^a,b   Amara, Margarida D ^b,c   Morimoto, Richard I ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF LISBON   (Portugal)

^c NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

Author keywords

Cholinergic neurons; GABAergic neurons; Polyglutamine aggregation; Protein misfolding; Protein polymorphisms

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; ACETYLCHOLINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; PROTEIN; PROTEIN UNC 30; UNCLASSIFIED DRUG;

ARTICLE; CAENORHABDITIS ELEGANS; HOMEOSTASIS; MUSCLE CELL; NONHUMAN; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN HOMEOSTASIS; SIGNAL TRANSDUCTION;

ACETYLCHOLINE; ALLELES; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; ETHYL METHANESULFONATE; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FLUORESCENT DYES; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; HOMEODOMAIN PROTEINS; HOMEOSTASIS; MOTOR NEURONS; MUSCLE PROTEINS; MUTAGENS; NEUROMUSCULAR JUNCTION; NUCLEAR PROTEINS; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEINS; SIGNAL TRANSDUCTION; SYNAPSES; TRANSGENES;

CAENORHABDITIS ELEGANS;

EID: 36248980418     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1575307     Document Type: Article

References (51)

1. Amaral, M.D. 2006. Therapy through chaperones: Sense or antisense? Cystic fibrosis as a model disease. J. Inherit. Metab. Dis. 29: 477-487.
2. Benmoyal-Segal, L. and Soreq, H. 2006. Gene-environment interactions in sporadic Parkinson's disease. J. Neurochem. 97: 1740-1755.
3. Boillee, S., Vande Velde, C., and Cleveland, D.W. 2006. ALS: A disease of motor neurons and their nonneuronal neighbors. Neuron 52: 39-59.
4. Brenner, S. 1974. The genetics of Caenorhabditis elegans. Genetics 77: 71-94.
5. Brignull, H.R., Moore, F.E., Tang, S.J., and Morimoto, R.I. 2006. Polyglutamine proteins at the pathogenic threshold display neuron-specific aggregation in a pan-neuronal Caenorhabditis elegans model. J. Neurosci. 26: 7597-7606.
6. Brignull, H.R., Morley, J.F., and Morimoto, R.I. 2007. The stress of misfolded proteins: C. elegans models for neurodegenerative disease and aging. Adv. Exp. Med. Biol. 594: 167-189.
7. Bruijn, L.I., Miller, T.M., and Cleveland, D.W. 2004. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27: 723-749.
8. Chen, S., Ferrone, F.A., and Wetzel, R. 2002. Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc. Natl. Acad. Sci. 99: 11884-11889.
9. Cohen, F.E. and Kelly, J.W. 2003. Therapeutic approaches to protein-misfolding diseases. Nature 426: 905-909.
10. Combes, D., Fedon, Y., Toutant, J.P., and Arpagaus, M. 2003. Multiple ace genes encoding acetylcholinesterases of Caenorhabditis elegans have distinct tissue expression. Eur. J. Neurosci. 18: 497-512.
11. + channel that coordinates muscle contraction in Caenorhabditis elegans. J. Neurosci. 23: 9133-9145.
12. Dobson, C.M. 2003. Protein folding and misfolding. Nature 426: 884-890.
13. Drysdale, M.J., Brough, P.A., Massey, A., Jensen, M.R., and Schoepfer, J. 2006. Targeting Hsp90 for the treatment of cancer. Curr. Opin. Drug Discov. Devel. 9: 483-495.
14. Faber, P.W., Alter, J.R., MacDonald, M.E., and Hart, A.C. 1999. Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron. Proc. Natl. Acad. Sci. 96: 179-184.
15. Finney, M. and Ruvkun, G. 1990. The unc-86 gene product couples cell lineage and cell identity in C. elegans. Cell 63: 895-905.
16. Gengyo-Ando, K. and Kagawa, H. 1991. Single charge change on the helical surface of the paramyosin rod dramatically disrupts thick filament assembly in Caenorhabditis elegans. J. Mol. Biol. 219: 429-441.
17. Gidalevitz, T., Ben-Zvi, A., Ho, K.H., Brignull, H.R., and Morimoto, R.I. 2006. Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science 311: 1471-1474.
18. Goodstadt, L. and Ponting, C.P. 2001. Sequence variation and disease in the wake of the draft human genome. Hum. Mol. Genet. 10: 2209-2214.
19. Gregersen, N. 2006. Protein misfolding disorders: Pathogenesis and intervention. J. Inherit. Metab. Dis. 29: 456-470.
20. Gusella, J.F. and MacDonald, M.E. 2000. Molecular genetics: Unmasking polyglutamine triggers in neurodegenerative disease. Nat. Rev. Neurosci. 1: 109-115.
21. Halapi, E. and Hakonarson, H. 2002. Advances in the development of genetic markers for the diagnosis of disease and drug response. Expert Rev. Mol. Diagn. 2: 411-421.
22. Hsu, A.L., Murphy, C.T., and Kenyon, C. 2003. Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science 300: 1142-1145.
23. Jin, Y., Hoskins, R., and Horvitz, H.R. 1994. Control of type-D GABAergic neuron differentiation by C. elegans UNC-30 homeodomain protein. Nature 372: 780-783.
24. Jin, Y., Jorgensen, E., Hartwieg, E., and Horvitz, H.R. 1999. The Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase and is required for synaptic transmission but not synaptic development. J. Neurosci. 19: 539-548.
25. 2+ channel EGL-19 controls body wall muscle function in Caenorhabditis elegans. J. Cell Biol. 159: 337-348.
26. Kimchi-Sarfaty, C., Oh, J.M., Kim, I.W., Sauna, Z.E., Calcagno, A.M., Ambudkar, S.V., and Gottesman, M.M. 2007. A 'silent' polymorphism in the MDR1 gene changes substrate specificity. Science 315: 525-528.
27. Lee, R.Y., Lobel, L., Hengartner, M., Horvitz, H.R., and Avery, L. 1997. Mutations in the α1 subunit of an L-type voltage-activated Ca2+ channel cause myotonia in Caenorhabditis elegans. EMBO J. 16: 6066-6076.
28. Lorenzo, L.E., Barbe, A., Portalier, P., Fritschy, J.M., and Bras, H. 2006. Differential expression of GABAA and glycine receptors in ALS-resistant vs. ALS-vulnerable motoneurons: Possible implications for selective vulnerability of motoneurons. Eur. J. Neurosci. 23: 3161-3170.
29. McIntire, S.L., Reimer, R.J., Schuske, K., Edwards, R.H., and Jorgensen, E.M. 1997. Identification and characterization of the vesicular GABA transporter. Nature 389: 870-876.
30. Morley, J.F., Brignull, H.R., Weyers, J.J., and Morimoto, R.I. 2002. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc. Natl. Acad. Sci. 99: 10417-10422.
31. Mularoni, L., Guigo, R., and Alba, M.M. 2006. Mutation patterns of amino acid tandem repeats in the human proteome. Genome Biol. 7: R33. doi: 10.1186/gb-2006-7-4-r33.
32. Nollen, E.A., Garcia, S.M., van Haaften, G., Kim, S., Chavez, A., Morimoto, R.I., and Plasterk, R.H. 2004. Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. Proc. Natl. Acad. Sci. 101: 6403-6408.
33. Parker, J.A., Connolly, J.B., Wellington, C., Hayden, M., Dausset, J., and Neri, C. 2001. Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death. Proc. Natl. Acad. Sci. 98: 13318-13323.
34. Queitsch, C., Sangster, T.A., and Lindquist, S. 2002. Hsp90 as a capacitor of phenotypic variation. Nature 417: 618-624.
35. Richmond, J.E. and Jorgensen, E.M. 1999. One GABA and two acetylcholine receptors function at the C. elegans neuromuscular junction. Nat. Neurosci. 2: 791-797.
36. Rogalski, T.M., Mullen, G.P., Bush, J.A., Gilchrist, E.J., and Moerman, D.G. 2001. UNC-52/perlecan isoform diversity and function in Caenorhabditis elegans. Biochem. Soc. Trans. 29: 171-176.
37. Rowland, A.M., Richmond, J.E., Olsen, J.G., Hall, D.H., and Bamber, B.A. 2006. Presynaptic terminals independently regulate synaptic clustering and autophagy of GABAA receptors in Caenorhabditis elegans. J. Neurosci. 26: 1711-1720.
38. Rusmini, P., Sau, D., Crippa, V., Palazzolo, I., Simonini, F., Onesto, E., Martini, L., and Poletti, A. 2007. Aggregation and proteasome: The case of elongated polyglutamine aggregation in spinal and bulbar muscular atrophy. Neurobiol. Aging 28: 1099-1111.
39. Rutherford, S.L. and Lindquist, S. 1998. Hsp90 as a capacitor for morphological evolution. Nature 396: 336-342.
40. Ruvkun, G. and Giusto, J. 1989. The Caenorhabditis elegans heterochronic gene lin-14 encodes a nuclear protein that forms a temporal developmental switch. Nature 338: 313-319.
41. Sangster, T.A., Lindquist, S., and Queitsch, C. 2004. Under cover: Causes, effects and implications of Hsp90-mediated genetic capacitance. Bioessays 26: 348-362.
42. Satyal, S.H., Schmidt, E., Kitagawa, K., Sondheimer, N., Lindquist, S., Kramer, J.M., and Morimoto, R.I. 2000. Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans. Proc. Natl. Acad. Sci. 97: 5750-5755.
43. Soto, C. 2003. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev. Neurosci. 4: 49-60.
44. Stefani, M. 2004. Protein misfolding and aggregation: New examples in medicine and biology of the dark side of the protein world. Biochim. Biophys. Acta 1739: 5-25.
45. Szewczyk, N.J., Hartman, J.J., Barmada, S.J., and Jacobson, L.A. 2000. Genetic defects in acetylcholine signalling promote protein degradation in muscle cells of Caenorhabditis elegans. J. Cell. Sci. 113: 2003-2010.
46. Voisine, C., Varma, H., Walker, N., Bates, E.A., Stockwell, B.R., and Hart, A.C. 2007. Identification of potential therapeutic drugs for Huntington's disease using Caenorhabditis elegans. PLoS ONE 2: e504. doi: 10.1371/journal.pone.0000504.
47. Warrick, J.M., Paulson, H.L., Gray-Board, G.L., Bui, Q.T., Fischbeck, K.H., Pittman, R.N., and Bonini, N.M. 1998. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 93: 939-949.
48. Wexler, N.S., Lorimer, J., Porter, J., Gomez, F., Moskowitz, C., Shackell, E., Marder, K., Penchaszadeh, G., Roberts, S.A., Gayan, J., et al. 2004. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc. Natl. Acad. Sci. 101: 3498-3503.
49. White, J.G., Albertson, D.G., and Anness, M.A. 1978. Connectivity changes in a class of motoneurone during the development of a nematode. Nature 271: 764-766.
50. Wicks, S.R., Yeh, R.T., Gish, W.R., Waterston, R.H., and Plasterk, R.H. 2001. Rapid gene mapping in Caenorhabditis elegans using a high density polymorphism map. Nat. Genet. 28: 160-164.
51. Zawia, N.H. and Basha, M.R. 2005. Environmental risk factors and the developmental basis for Alzheimer's disease. Rev. Neurosci. 16: 325-337.